Cite
Circulating Omentin-1 as a Biomarker at the Intersection of Postmenopausal Breast Cancer Occurrence and Cardiometabolic Risk: An Observational Cross-Sectional Study
MLA
Gerasimos Socrates Christodoulatos, et al. “Circulating Omentin-1 as a Biomarker at the Intersection of Postmenopausal Breast Cancer Occurrence and Cardiometabolic Risk: An Observational Cross-Sectional Study.” Biomolecules, vol. 11, no. 11, Oct. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....67aa78276f5148a0591305308f97342e&authtype=sso&custid=ns315887.
APA
Gerasimos Socrates Christodoulatos, Sotiria Psallida, Georgios Antonakos, Theodora Stratigou, Maria Dalamaga, Irene Karampela, Styliani I. Kokoris, Ioanna Marinou, Athanasios G. Papavassiliou, Antigoni Lekka, Evaggelos Vogiatzakis, & Natalia G. Vallianou. (2021). Circulating Omentin-1 as a Biomarker at the Intersection of Postmenopausal Breast Cancer Occurrence and Cardiometabolic Risk: An Observational Cross-Sectional Study. Biomolecules, 11(11).
Chicago
Gerasimos Socrates Christodoulatos, Sotiria Psallida, Georgios Antonakos, Theodora Stratigou, Maria Dalamaga, Irene Karampela, Styliani I. Kokoris, et al. 2021. “Circulating Omentin-1 as a Biomarker at the Intersection of Postmenopausal Breast Cancer Occurrence and Cardiometabolic Risk: An Observational Cross-Sectional Study.” Biomolecules 11 (11). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....67aa78276f5148a0591305308f97342e&authtype=sso&custid=ns315887.